SUTRO BIOPHARMA INC (STRO) Stock Income Statement
USA - NASDAQ:STRO - US8693671021 - Common Stock
0.8469 USD
0 (-0.36%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 105.65M | 62.04M | 153.73M | 67.77M | 61.88M | |||
| Operating Expenses | 242.13M | 300.50M | 243.01M | 196.72M | 160.40M | |||
| Research and Development | 200.81M | 252.04M | 180.43M | 137.17M | 104.40M | |||
| Selling, General, and Administrative Expenses | 41.39M | 48.45M | 62.58M | 59.54M | 56.00M | |||
| Operating Income | -136.29M | -238.45M | -89.28M | -128.94M | -98.52M | |||
| Interest Income/Expense | 8.50M | 44.42M | 13.25M | 12.24M | -7.01M | |||
| Other Income/Expense | -37.35M | -31.07M | -12.57M | N/A | N/A | |||
| Income Before Taxes | -214.34M | -225.10M | -88.60M | -116.70M | -105.54M | |||
| Income Tax | N/A | 2.36M | 18.19M | 2.50M | N/A | |||
| Net Income | -216.32M | -227.46M | -106.79M | -119.20M | -105.54M | |||
| EBITDA | -128.72M | -231.24M | -82.46M | -123.25M | -93.68M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.60 | -2.96 | -1.78 | -2.35 | -2.29 | |||
| Non GAAP EPS | -2.61 | -3.02 | -1.78 | -2.44 | -2.29 | |||
| Statistics | ||||||||
| Profit Margin | -204.76% | -366.62% | -69.47% | -175.89% | -170.56% | |||
| Operating Profit Margin | -129.01% | -384.34% | -58.07% | -190.26% | -159.21% | |||
All data in USD